President Donald Trump’s tariffs have two primary objectives. One is to rebalance the world trade order, which he believes is ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...